Guidelines

Practical guidelines in axillary management after neo-adjuvant chemotherapy in breast cancer patients
Clinical management of first-line advanced triple-negative breastcancer patients
Systemic treatment landscape and algorithm for hormone-receptor positive, HER2 negative advanced breast cancer
An update on the management of metastatic clear-cell renal cell carcinoma: the BSMO expert panel recommendations
Belgian consensus guidelines for prostate core needle biopsy reporting
PD-L1 Testing for Non-Small Cell Lung Cancer: Belgian Guidelines
Prevention of chemotherapy-induced nausea and vomiting: Belgian antiemetic treatment options anno 2018
The ION-Ghent guidelines for the management of immune related adverse events (irAE’s)
The Belgian next generation sequencing guidelines for haematological and solid tumours
Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines
Adjuvant endocrine therapy in preand perimenopausal women with breast cancer: practice guidelines
Molecular diagnostics on tissue samples obtained through EBUSTBNA: review on practice guidelines
RAS-testing in colorectal cancer: Belgian guidelines
Early detection of prostate cancer: the EAU versus the AUA recommendation
Penile cancer practice guidelines
Update of the Belgian guidelines for HER2 testing in breast cancer
Belgian Society of Medical Oncology (BSMO) task force on breast cancer survivorship
Soft tissue sarcoma: the clinically relevant basics and an update on systemic therapy options for patients with advanced disease
Practical guidelines in the management of uveal melanoma
Belgian guidelines for laboratory handling and pathology reporting of breast carcinoma after neoadjuvant therapy
Belgian guidelines for HER2 testing in gastric cancer
Belgian consensus guidelines for the subtyping of NSCLC
Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapyinduced anemia
Belgian guidelines for HER2/neu testing in breast cancer

X